Y42C (p.Tyr42Cys) variant of NFKBIA (NF-kappa-B inhibitor alpha)
Y42C (p.Tyr42Cys) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
Y42C (p.Tyr42Cys) variant details
- p.Tyr42Cys
- NCI-TCGA Cosmic COSV5375
- cosmic curated COSV53751
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.72
- MetaSVM 0.46
- SIFT 0.09
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available